Atlas Trials

Specificity Trial of the Recombinant Tuberculosis Allergen in BCG Vaccinated Healthy Volunteers

Clinical trial NCT05203068 · COMPLETED

Trial details

NCT number
NCT05203068
Sponsor
National Medical Research Center of Phthisiopulmonology and Infectious Diseases
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Tuberculosis
Start date
2021-11-24
Primary completion
2022-01-18
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.